CHRISTIANSTED, U.S. Virgin Islands, Oct. 25, 2017 -- Altisource Residential Corporation (“RESI”) (NYSE:RESI) will report earnings results for the third quarter of 2017 on Tuesday, November 7, 2017. RESI will also host a conference call at 8:30 a.m. Eastern Time on November 7, 2017 to discuss its third quarter results. A link to the live audio webcast will be available on RESI’s website at www.altisourceresi.com through the Shareholders home page.
Those who want to listen to the call should go to the website at least fifteen minutes prior to the call to register, download and install any necessary audio software. A replay of the conference call will be available via the website approximately two hours after the conclusion of the call and will remain available for approximately 30 days.
About Altisource Residential Corporation
RESI is focused on providing quality, affordable rental homes to families throughout the United States. Additional information is available at www.altisourceresi.com.
| FOR FURTHER INFORMATION CONTACT: Robin N. Lowe Chief Financial Officer T: +1-345-815-9919 E: [email protected] |


Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 



